Literature DB >> 56444

Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicity.

S H Golub, D C Hanson, H L Sulit, D L Morton, M A Pellegrino, S Ferrone.   

Abstract

Human tumor and febroblast tissue culture cells were compared to determine the suitability of fibroblasts as control cells in experiments on human tumor serology and cellular immunology. Fibroblasts expressed the same HL-A antigen profile as did melanoma cells. Furthermore, the quantitative expression of the determinants was similar on both cell types. In four of five pairs tested, the fibroblasts displayed similar sensitivity to effector cells generated by mixed lymphocyte culture as did the tumor cells from the same donor, but there were some differences in the effects of specific alloimmune effector cells at high and low effector-to-target ratios on the two types of target cells. Results indicated that fibroblasts are legitimate control target cells for studies in human tumor immunology, if screening assays are done to verify their antigenicity and sensitivity to cell-mediated cytolysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56444     DOI: 10.1093/jnci/56.1.167

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule.

Authors:  R L Ceriani; K Thompson; J A Peterson; S Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia.

Authors:  G Starace; G Badaracco; A Bertuzzi; A Gandolfi; C Greco; M D Totaro; R Vitelli; G Zupi
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.

Authors:  Francesca Spinella; Laura Rosanò; Martina Del Duca; Valeriana Di Castro; Maria Rita Nicotra; Pier Giorgio Natali; Anna Bagnato
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

4.  NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.

Authors:  Simona Caporali; Lauretta Levati; Grazia Graziani; Alessia Muzi; Maria Grazia Atzori; Enzo Bonmassar; Giuseppe Palmieri; Paolo A Ascierto; Stefania D'Atri
Journal:  J Transl Med       Date:  2012-12-21       Impact factor: 5.531

5.  Mitozolomide activity on human cancer cells in vitro.

Authors:  E Erba; S Pepe; P Ubezio; A Lorico; L Morasca; C Mangioni; F Landoni; M D'Incalci
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.